Portugal's FHC is entering South Africa's sterile injectables market, planning to build a local plant to challenge established players.
You must be a subscriber to access all of this content.
Explore the calls for drug company nationalisation in South Africa amid rising job cuts and concerns in the pharmaceutical industry.
You must be a subscriber to access all of this content.
The excessive Dialysis Product Pricing case targets Adcock Ingram, with a possible 10% turnover penalty and wider renal care cost impacts.
You must be a subscriber to access all of this content.
...
You must be a subscriber to access all of this content.
Adcock Ingram delisting from the JSE is confirmed for November 11. Learn about the impact of the Natco Pharma acquisition.
You must be a subscriber to access all of this content.